The development of nanocarriers for natural products
WIREs Nanomedicine and Nanobiotechnology · 2024-05 · 16 (3)
DOI: 10.1002/wnan.1967 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, online erschienen am 16.05.2024. Verfasst von Liying Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Microcosmic Syndrome Differentiation, Yunnan University of Chinese Medicine, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Biological Products, Drug Carriers. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 502 Literaturangaben. Gefördert von: Open Project of Yunnan Clinical Medical Research Center for Geriatric Diseases.
Abstract (Originalsprache)
Natural bioactive compounds from plants exhibit substantial pharmacological potency and therapeutic value. However, the development of most plant bioactive compounds is hindered by low solubility and instability. Conventional pharmaceutical forms, such as tablets and capsules, only partially overcome these limitations, restricting their efficacy. With the recent development of nanotechnology, nanocarriers can enhance the bioavailability, stability, and precise intracellular transport of plant bioactive compounds. Researchers are increasingly integrating nanocarrier‐based drug delivery systems (NDDS) into the development of natural plant compounds with significant success. Moreover, natural products benefit from nanotechnological enhancement and contribute to the innovation and optimization of nanocarriers via self‐assembly, grafting modifications, and biomimetic designs. This review aims to elucidate the collaborative and reciprocal advancement achieved by integrating nanocarriers with botanical products, such as bioactive compounds, polysaccharides, proteins, and extracellular vesicles. This review underscores the salient challenges in nanomedicine, encompassing long‐term safety evaluations of nanomedicine formulations, precise targeting mechanisms, biodistribution complexities, and hurdles in clinical translation. Further, this study provides new perspectives to leverage nanotechnology in promoting the development and optimization of natural plant products for nanomedical applications and guiding the progression of NDDS toward enhanced efficiency, precision, and safety. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory of Microcosmic Syndrome Differentiation, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
- Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
- Yunnan Clinical Medical Research Center for Geriatric Diseases, Yunnan First People's Hospital, Kunming, Yunnan, China.
ORCID-Profile: Junzi Wu
Förderung
- Open Project of Yunnan Clinical Medical Research Center for Geriatric Diseases
Zitieren
APA
Huang, L., Luo, S., Tong, S., Lv, Z., & Wu, J. (2024). The development of nanocarriers for natural products. WIREs Nanomedicine and Nanobiotechnology, 16(3). https://doi.org/10.1002/wnan.1967
Vancouver
Huang L, Luo S, Tong S, Lv Z, Wu J. The development of nanocarriers for natural products. WIREs Nanomedicine and Nanobiotechnology. 2024;16(3). doi:10.1002/wnan.1967
BibTeX
@article{Huang2024,
author = {Huang, Liying and Luo, Shicui and Tong, Sen and Lv, Zhuo and Wu, Junzi},
title = {The development of nanocarriers for natural products},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2024},
volume = {16},
number = {3},
doi = {10.1002/wnan.1967}
}
EUVIMED